Abstract
The human endometrium is a unique, highly dynamic tissue that undergoes cyclic changes of cell proliferation, differentiation, and death. Endometrial cancer is the most common malignancy among women in developed countries. Importantly, the incidence of endometrial cancer is rising in high-income countries. Currently histological classification is used for subtyping of endometrial cancer, while ongoing research is evaluating markers for more accurate molecular classification. Evolutionary conserved Notch signaling pathway regulates diverse cellular processes such as proliferation, differentiation, and cell invasion. Accumulating evidence links aberrant Notch signaling with diseases such as hyperplasia and endometrial cancer. This chapter summarizes the current state of Notch signaling investigations in the endometrium, endometriosis, and endometrial cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Afshar Y, Jeong JW, Roqueiro D, DeMayo F, Lydon J, Radtke F, Radnor R, Miele L, Fazleabas A (2012) Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse. FASEB J 26(1):282–294. https://doi.org/10.1096/fj.11-184663
Aghajanova L, Shen S, Rojas AM, Fisher SJ, Irwin JC, Giudice LC (2012) Comparative transcriptome analysis of human trophectoderm and embryonic stem cell-derived trophoblasts reveal key participants in early implantation. Biol Reprod 86(1):1–21. https://doi.org/10.1095/biolreprod.111.092775
Akhtar M, Al Hyassat S, Elaiwy O, Rashid S, Al-Nabet A (2019) Classification of endometrial carcinoma: new perspectives beyond morphology. Adv Anat Pathol 26(6):421–427. https://doi.org/10.1097/PAP.0000000000000251
Amant F, Mirza MR, Koskas M, Creutzberg CL (2018) Cancer of the corpus uteri. Int J Gynaecol Obstet 143(Suppl 2):37–50. https://doi.org/10.1002/ijgo.12612
Amjadi F, Salehi E, Zandieh Z, Rashidi M, Taleahmad S, Javedani Masrour M, Aflatoonian R, Mehdizadeh M (2019) Comparative evaluation of NOTCH signaling molecules in the endometrium of women with various gynecological diseases during the window of implantation. Iran J Basic Med Sci 22(4):426–431. https://doi.org/10.22038/ijbms.2019.32961.7874
Ando S, Barone I, Giordano C, Bonofiglio D, Catalano S (2014) The multifaceted mechanism of leptin signaling within tumor microenvironment in driving breast cancer growth and progression. Front Oncol 4:340. https://doi.org/10.3389/fonc.2014.00340
Banerjee P, Fazleabas AT (2011) Extragonadal actions of chorionic gonadotropin. Rev Endocr Metab Disord 12(4):323–332. https://doi.org/10.1007/s11154-011-9193-1
Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1):10–17. https://doi.org/10.1016/0090-8258(83)90111-7
Brar AK, Handwerger S, Kessler CA, Aronow BJ (2001) Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization. Physiol Genomics 7(2):135–148. https://doi.org/10.1152/physiolgenomics.00061.2001
Cancer Genome Atlas Research N, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67–73. https://doi.org/10.1038/nature12113
Carlson J, McCluggage WG (2019) Reclassifying endometrial carcinomas with a combined morphological and molecular approach. Curr Opin Oncol 31(5):411–419. https://doi.org/10.1097/CCO.0000000000000560
Carvalho MJ, Laranjo M, Abrantes AM, Torgal I, Botelho MF, Oliveira CF (2015) Clinical translation for endometrial cancer stem cells hypothesis. Cancer Metastasis Rev 34(3):401–416. https://doi.org/10.1007/s10555-015-9574-0
Cobellis L, Caprio F, Trabucco E, Mastrogiacomo A, Coppola G, Manente L, Colacurci N, De Falco M, De Luca A (2008) The pattern of expression of Notch protein members in normal and pathological endometrium. J Anat 213(4):464–472. https://doi.org/10.1111/j.1469-7580.2008.00963.x
Crean-Tate KK, Reizes O (2018) Leptin regulation of cancer stem cells in breast and gynecologic Cancer. Endocrinology 159(8):3069–3080. https://doi.org/10.1210/en.2018-00379
Cuman C, Menkhorst EM, Rombauts LJ, Holden S, Webster D, Bilandzic M, Osianlis T, Dimitriadis E (2013) Preimplantation human blastocysts release factors that differentially alter human endometrial epithelial cell adhesion and gene expression relative to IVF success. Hum Reprod 28(5):1161–1171. https://doi.org/10.1093/humrep/det058
Cuman C, Menkhorst E, Winship A, Van Sinderen M, Osianlis T, Rombauts LJ, Dimitriadis E (2014) Fetal-maternal communication: the role of Notch signalling in embryo implantation. Reproduction 147(3):R75–R86. https://doi.org/10.1530/REP-13-0474
Daley-Brown D, Oprea-Ilies GM, Lee R, Pattillo R, Gonzalez-Perez RR (2015) Molecular cues on obesity signals, tumor markers and endometrial cancer. Horm Mol Biol Clin Invest 21(1):89–106. https://doi.org/10.1515/hmbci-2014-0049
Daley-Brown D, Harbuzariu A, Kurian AA, Oprea-Ilies G, Gonzalez-Perez RR (2019) Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance. World J Clin Oncol 10(6):222–233. https://doi.org/10.5306/wjco.v10.i6.222
Devor EJ, Miecznikowski J, Schickling BM, Gonzalez-Bosquet J, Lankes HA, Thaker P, Argenta PA, Pearl ML, Zweizig SL, Mannel RS, Brown A, Ramirez NC, Ioffe OB, Park KJ, Creasman WT, Birrer MJ, Mutch D, Leslie KK (2017) Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: an NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol 147(3):648–653. https://doi.org/10.1016/j.ygyno.2017.09.025
Diedrich K, Fauser BC, Devroey P, Griesinger G, Evian Annual Reproduction Workshop G (2007) The role of the endometrium and embryo in human implantation. Hum Reprod Update 13(4):365–377. https://doi.org/10.1093/humupd/dmm011
Elbasateeny SS, Salem AA, Abdelsalam WA, Salem RA (2016) Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer. Pathol Res Pract 212(1):10–16. https://doi.org/10.1016/j.prp.2015.10.008
Er TK, Su YF, Wu CC, Chen CC, Wang J, Hsieh TH, Herreros-Villanueva M, Chen WT, Chen YT, Liu TC, Chen HS, Tsai EM (2016) Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer. J Mol Med 94(7):835–847. https://doi.org/10.1007/s00109-016-1395-2
Evans J, Salamonsen LA, Winship A, Menkhorst E, Nie G, Gargett CE, Dimitriadis E (2016) Fertile ground: human endometrial programming and lessons in health and disease. Nat Rev Endocrinol 12(11):654–667. https://doi.org/10.1038/nrendo.2016.116
Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005
Giannone G, Attademo L, Scotto G, Genta S, Ghisoni E, Tuninetti V, Aglietta M, Pignata S, Valabrega G (2019) Endometrial cancer stem cells: role, characterization and therapeutic implications. Cancers 11(11). https://doi.org/10.3390/cancers11111820
Gotte M, Greve B, Kelsch R, Muller-Uthoff H, Weiss K, Kharabi Masouleh B, Sibrowski W, Kiesel L, Buchweitz O (2011) The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1. In J Cancer 129(8):2042–2049. https://doi.org/10.1002/ijc.25856
Guo S, Gonzalez-Perez RR (2011) Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer. PLoS One 6(6):e21467. https://doi.org/10.1371/journal.pone.0021467
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013
Hickey M, Ballard K, Farquhar C (2014) Endometriosis. BMJ 348:g1752. https://doi.org/10.1136/bmj.g1752
Jonusiene V, Sasnauskiene A, Lachej N, Kanopiene D, Dabkeviciene D, Sasnauskiene S, Kazbariene B, Didziapetriene J (2013) Down-regulated expression of Notch signaling molecules in human endometrial cancer. Med Oncol 30(1):438. https://doi.org/10.1007/s12032-012-0438-y
Jurcevic S, Olsson B, Klinga-Levan K (2014) MicroRNA expression in human endometrial adenocarcinoma. Cancer Cell Int 14(1):88. https://doi.org/10.1186/s12935-014-0088-6
Jurcevic S, Klinga-Levan K, Olsson B, Ejeskar K (2016) Verification of microRNA expression in human endometrial adenocarcinoma. BMC Cancer 16:261. https://doi.org/10.1186/s12885-016-2296-z
Li N, Zhang L, Li Q, Du Y, Liu H, Liu Y, Xiong W (2018) Notch activity mediates oestrogen-induced stromal cell invasion in endometriosis. Reproduction 157(4):371–381. https://doi.org/10.1530/REP-18-0326
Ma L, Xu YL, Ding WJ, Shao HF, Teng YC (2015) Prognostic value of Musashi-1 in endometrioid adenocarcinoma. Int J Clin Exp Pathol 8(5):4564–4572
Maruyama T, Yoshimura Y (2008) Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium. Endocr J 55(5):795–810. https://doi.org/10.1507/endocrj.k08e-067
Matias-Guiu X, Prat J (2013) Molecular pathology of endometrial carcinoma. Histopathology 62(1):111–123. https://doi.org/10.1111/his.12053
McConechy MK, Ding J, Cheang MC, Wiegand K, Senz J, Tone A, Yang W, Prentice L, Tse K, Zeng T, McDonald H, Schmidt AP, Mutch DG, McAlpine JN, Hirst M, Shah SP, Lee CH, Goodfellow PJ, Gilks CB, Huntsman DG (2012) Use of mutation profiles to refine the classification of endometrial carcinomas. J Pathol 228(1):20–30. https://doi.org/10.1002/path.4056
Mikhailik A, Mazella J, Liang S, Tseng L (2009) Notch ligand-dependent gene expression in human endometrial stromal cells. Biochem Biophys Res Commun 388(3):479–482. https://doi.org/10.1016/j.bbrc.2009.07.037
Mitsuhashi Y, Horiuchi A, Miyamoto T, Kashima H, Suzuki A, Shiozawa T (2012) Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells. Histopathology 60(5):826–837. https://doi.org/10.1111/j.1365-2559.2011.04158.x
Mori M, Miyamoto T, Ohno S, Miyake Y, Sakaguchi T, Ohno E (2012) Diagnostic utility of notch-1 immunocytochemistry in endometrial cytology. Acta Cytol 56(2):166–170. https://doi.org/10.1159/000335485
O’Hara AJ, Bell DW (2012) The genomics and genetics of endometrial cancer. Adv Genom Genet 2012(2):33–47. https://doi.org/10.2147/AGG.S28953
Otti GR, Saleh L, Velicky P, Fiala C, Pollheimer J, Knofler M (2014) Notch2 controls prolactin and insulin-like growth factor binding protein-1 expression in decidualizing human stromal cells of early pregnancy. PLoS One 9(11):e112723. https://doi.org/10.1371/journal.pone.0112723
Pathiraja P, Dhar S, Haldar K (2013) Serous endometrial intraepithelial carcinoma: a case series and literature review. Cancer Manag Res 5:117–122. https://doi.org/10.2147/CMAR.S45141
Polychronidou G, Kotoula V, Manousou K, Kostopoulos I, Karayannopoulou G, Vrettou E, Bobos M, Raptou G, Efstratiou I, Dionysopoulos D, Chatzopoulos K, Lakis S, Chrisafi S, Tsolakidis D, Papanikolaou A, Dombros N, Fountzilas G (2018) Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer. PLoS One 13(12):e0208221. https://doi.org/10.1371/journal.pone.0208221
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study C (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335(7630):1134. https://doi.org/10.1136/bmj.39367.495995.AE
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578. https://doi.org/10.1016/S0140-6736(08)60269-X
Ruiz-Alonso M, Blesa D, Simon C (2012) The genomics of the human endometrium. Biochim Biophys Acta 1822(12):1931–1942. https://doi.org/10.1016/j.bbadis.2012.05.004
Salamonsen LA (2019) WOMEN IN REPRODUCTIVE SCIENCE: my WOMBan’s life: understanding human endometrial function. Reproduction 158(6):F55–F67. https://doi.org/10.1530/REP-18-0518
Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT (2017) New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update 23(2):232–254. https://doi.org/10.1093/humupd/dmw042
Sasnauskiene A, Jonusiene V, Krikstaponiene A, Butkyte S, Dabkeviciene D, Kanopiene D, Kazbariene B, Didziapetriene J (2014) NOTCH1, NOTCH3, NOTCH4, and JAG2 protein levels in human endometrial cancer. Medicina 50(1):14–18. https://doi.org/10.1016/j.medici.2014.05.002
Schmandt RE, Iglesias DA, Co NN, Lu KH (2011) Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol 205(6):518–525. https://doi.org/10.1016/j.ajog.2011.05.042
Schuring AN, Dahlhues B, Korte A, Kiesel L, Titze U, Heitkotter B, Ruckert C, Gotte M (2018) The endometrial stem cell markers notch-1 and numb are associated with endometriosis. Reprod Biomed Online 36(3):294–301. https://doi.org/10.1016/j.rbmo.2017.11.010
Shang C, Lang B, Meng LR (2018) Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells. Cancer Biol Ther 19(2):113–119. https://doi.org/10.1080/15384047.2016.1250985
Su RW, Strug MR, Joshi NR, Jeong JW, Miele L, Lessey BA, Young SL, Fazleabas AT (2015) Decreased Notch pathway signaling in the endometrium of women with endometriosis impairs decidualization. J Clin Endocrinol Metab 100(3):E433–E442. https://doi.org/10.1210/jc.2014-3720
Su RW, Strug MR, Jeong JW, Miele L, Fazleabas AT (2016) Aberrant activation of canonical Notch1 signaling in the mouse uterus decreases progesterone receptor by hypermethylation and leads to infertility. Proc Natl Acad Sci U S A 113(8):2300–2305. https://doi.org/10.1073/pnas.1520441113
Sundar S, Balega J, Crosbie E, Drake A, Edmondson R, Fotopoulou C, Gallos I, Ganesan R, Gupta J, Johnson N, Kitson S, Mackintosh M, Martin-Hirsch P, Miles T, Rafii S, Reed N, Rolland P, Singh K, Sivalingam V, Walther A (2017) BGCS uterine cancer guidelines: recommendations for practice. Eur J Obstet Gynecol Reprod Biol 213:71–97. https://doi.org/10.1016/j.ejogrb.2017.04.015
Suzuki T, Aoki D, Susumu N, Udagawa Y, Nozawa S (2000) Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers. Int J Oncol 17(6):1131–1139. https://doi.org/10.3892/ijo.17.6.1131
Tempest N, Maclean A, Hapangama DK (2018) Endometrial stem cell markers: current concepts and unresolved questions. Int J Mol Sci 19(10). https://doi.org/10.3390/ijms19103240
Townsend MH, Ence ZE, Felsted AM, Parker AC, Piccolo SR, Robison RA, O’Neill KL (2019) Potential new biomarkers for endometrial cancer. Cancer Cell Int 19:19. https://doi.org/10.1186/s12935-019-0731-3
Trabucco SE, Gowen K, Maund SL, Sanford E, Fabrizio DA, Hall MJ, Yakirevich E, Gregg JP, Stephens PJ, Frampton GM, Hegde PS, Miller VA, Ross JS, Hartmaier RJ, Huang SA, Sun JX (2019) A novel next-generation sequencing approach to detecting microsatellite instability and pan-tumor characterization of 1000 microsatellite instability-high cases in 67,000 patient samples. J Mol Diagnost 21(6):1053–1066. https://doi.org/10.1016/j.jmoldx.2019.06.011
Urick ME, Bell DW (2019) Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer 19(9):510–521. https://doi.org/10.1038/s41568-019-0177-x
Van Sinderen M, Cuman C, Gamage T, Rainczuk K, Osianlis T, Rombauts L, Dimitriadis E (2014) Localisation of the Notch family in the human endometrium of fertile and infertile women. J Mol Histol 45(6):697–706. https://doi.org/10.1007/s10735-014-9587-y
Wang J, Zhang K, Liu Z, Wang T, Shi F, Zhang Y, Su J, Jia Y (2018) Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer: a retrospective study. Medicine 97(51):e13442. https://doi.org/10.1097/MD.0000000000013442
Williams E, Villar-Prados A, Bowser J, Broaddus R, Gladden AB (2017) Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling. PLoS One 12(12):e0189081. https://doi.org/10.1371/journal.pone.0189081
World Cancer Research Fund. https://www.wcrf.org/dietandcancer/cancertrends/endometrial-cancer-statistics. Accessed October 23, 2019
Yu HC, Lin CY, Chang WC, Shen BJ, Chang WP, Chuang CM, Task Force on Carcinogenesis of Endometrial C (2015) Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study. Int J Gynecol Cancer 25(3):447–452. https://doi.org/10.1097/IGC.0000000000000384
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jonusiene, V., Sasnauskiene, A. (2021). Notch and Endometrial Cancer. In: Reichrath, J., Reichrath, S. (eds) Notch Signaling in Embryology and Cancer. Advances in Experimental Medicine and Biology, vol 1287. Springer, Cham. https://doi.org/10.1007/978-3-030-55031-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-55031-8_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-55030-1
Online ISBN: 978-3-030-55031-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)